This test is most useful if any of these apply to you.
Around the middle of the night, your body's main stress hormone should be at its quietest point of the entire day. If that quiet does not happen, something in your stress-regulation system is staying switched on while you sleep. This saliva test captures a snapshot of that mid-sleep low point.
Most lab panels never look at this window. They check a single morning cortisol or run a daytime panel that misses the night entirely. The mid-sleep value answers a narrower question: when your stress system should be at its calmest, is it calming down?
The molecule being measured is cortisone, the inactive cousin of cortisol (the main stress hormone made by your adrenal glands). In saliva, an enzyme expressed in the salivary glands (called 11β-HSD2) converts most cortisol into cortisone, so salivary cortisone closely tracks the free, biologically active cortisol circulating in your blood. The S0 timepoint is collected during the middle of your sleep period, when cortisol and cortisone should reach their natural low point.
In healthy adults studied with continuous around-the-clock sampling, tissue cortisone fell to its lowest level after sleep onset, with the nadir typically falling between roughly 10 p.m. and 2 a.m., and began rising several hours before waking. This rhythm is one of the most reliable signals of a properly functioning stress-control system, scientifically known as the hypothalamic-pituitary-adrenal (HPA) axis.
A few caveats up front. While late-night (around 11 p.m.) salivary cortisone has established reference ranges and diagnostic cutoffs for screening Cushing's syndrome, the specific mid-sleep timepoint used here is more research-grade and lacks universally standardized clinical cutpoints. Most of the disease-association evidence below comes from studies of cortisol (not cortisone) or from late-night sampling timed slightly differently. The mid-sleep value is best read as one piece of a larger circadian picture, not a yes-or-no diagnostic in isolation.
The most established clinical use for late-night salivary steroid testing is screening for Cushing's syndrome, a condition where the body produces too much cortisol. The defining feature is loss of the normal nocturnal nadir: levels stay elevated when they should be falling.
Late-night salivary cortisone measured by mass spectrometry has been studied as a screening tool for hypercortisolism, with reported sensitivity and specificity broadly in the 90 to 100 percent range across studies, depending on the assay method and cutoff used. In obese children with clinical features suggesting Cushing's, late-night salivary cortisol identified every confirmed case and cleared every unaffected child in one cohort.
There is also growing evidence that salivary cortisone may be a better marker than salivary cortisol for milder forms of cortisol excess, especially in adrenal incidentaloma cases (small benign-looking adrenal nodules found on imaging). In one study, late-night salivary cortisone identified 9 of 10 patients with autonomous cortisol secretion from adrenal incidentalomas, compared to 4 of 10 detected by late-night salivary cortisol. Salivary cortisone is also less easily contaminated by topical hydrocortisone creams, licorice intake, or trace blood in the mouth, all of which can falsely raise salivary cortisol but barely touch cortisone.
Sleep and the HPA axis are tightly looped. When sleep is short, fragmented, or chronically poor, the normal day-to-night drop in cortisol flattens out, and nighttime levels stay higher than they should. In a 15-day intensive longitudinal study, higher pre-sleep cortisol predicted shorter sleep duration and lower sleep efficiency that night.
Across mid-life women, higher hair cortisone (a three-month integrated measure of glucocorticoid exposure) was tied to longer time to fall asleep and worse self-reported sleep on the Pittsburgh Sleep Quality Index. Lower hair cortisol tracked with better sleep efficiency. These correlations are modest, but they point in a consistent direction: more chronic stress hormone exposure, worse sleep.
A flatter diurnal cortisol slope (the day-to-night drop) and elevated nighttime cortisol have been repeatedly linked to obesity, type 2 diabetes, atherosclerosis, and broader cardiometabolic risk. In the Whitehall II study, people with type 2 diabetes had a flatter cortisol decline across the day and higher bedtime cortisol than those without diabetes.
A meta-analysis pooling 80 studies found that flatter diurnal cortisol slopes were associated with worse mental and physical health outcomes, including higher mortality. In Whitehall II specifically, flatter slopes predicted cardiovascular mortality, and in the KORA-F3 cohort, elevated late-night cortisol predicted cardiovascular mortality.
These findings come from studies measuring cortisol slopes and timepoints, not mid-sleep cortisone specifically. Whether the same risk gradient holds for mid-sleep salivary cortisone has not been directly tested, but because salivary cortisone closely tracks free cortisol, an elevated mid-sleep value likely reflects the same underlying pattern of incomplete nighttime quieting.
Elevated evening and night cortisol shows up across several mood-related conditions. In adults with bipolar disorder, cortisol at 10 p.m. was significantly higher than in matched controls, suggesting impaired evening cortisol attenuation. In recurrent major depression, higher evening cortisol has been linked to altered fatty acid metabolism. In long COVID, cortisol rhythms are blunted, and circadian timing is disrupted.
A prospective cohort of community-dwelling adults found that blunted early and mid-morning cortisol declines predicted incident chronic multisite pain over a median of 7.6 years, with people in the most blunted group roughly twice as likely to develop chronic pain as those with the steepest declines, after adjusting for sociodemographic, lifestyle, and health factors.
In a study of 97 women with advanced breast cancer, an aberrant nocturnal cortisol spike during sleep was correlated with a shorter disease-free interval. This is not a population screening finding, but it underscores that what happens to cortisol during sleep is biologically meaningful, not just a quirk of the rhythm.
A single mid-sleep cortisone value is noisier than most people assume. Salivary steroid levels swing meaningfully day to day based on what time you went to sleep, how the night went, whether you woke briefly to provide the sample, and what your week has looked like. One reading captures a moment, not a pattern.
Get a baseline, then retest in 3 to 6 months if you are actively making changes (sleep hygiene, stress practices, exercise programming, or medications). After that, an annual or twice-yearly check is reasonable if you are using this number to guide HPA axis or sleep work. The value is in seeing whether your nighttime nadir is deepening over time, not in chasing one number across the threshold.
If you are using this test to track an intervention, pair it with the other points in your diurnal cortisol curve and with sleep metrics (total sleep time, efficiency, awakenings). A mid-sleep value that is shifting in isolation, while your morning peak and daytime decline look unchanged, may reflect collection variability more than real biology.
An elevated mid-sleep cortisone value, especially alongside an elevated bedtime cortisone and a flat daily slope, is the pattern that warrants further work. If your clinical context includes weight gain, central obesity, easy bruising, hypertension, new-onset diabetes, or osteoporosis, the next step is a formal Cushing's workup: a 1 milligram overnight dexamethasone suppression test, 24-hour urinary free cortisol, and repeat late-night salivary cortisol or cortisone. An endocrinologist should be involved if any of these are abnormal.
If the elevation is mild and your clinical picture is dominated by sleep, mood, or chronic stress, the more useful pathway is to investigate the upstream drivers (sleep architecture, circadian alignment, mental health, training load) rather than chasing a Cushing's workup. Pair this test with markers of metabolic stress (fasting insulin, HbA1c, triglycerides) and inflammation (hs-CRP, which is high-sensitivity C-reactive protein) to see whether the cortisol pattern is part of a larger cardiometabolic signal.
A low mid-sleep cortisone is harder to interpret on its own. If morning cortisol or cortisone is also low and you have unexplained fatigue, weight loss, low blood pressure, or salt cravings, adrenal insufficiency should be evaluated with a morning cortisol and ACTH (a pituitary hormone that signals the adrenals), followed by a stimulation test if those are abnormal.
Evidence-backed interventions that affect your Cortisone - Mid Sleep level
Cortisone - Mid Sleep is best interpreted alongside these tests.
Cortisone - Mid Sleep is included in these pre-built panels.